Therefore, to sensitize lung cancer cell to the chemotherapeutic effect of LMB, we herein propose a therapeutic strategy combining LMB with other drugs by inducing severe DNA damage and p53 activation which could eventually lead to increased function of p53 in apoptosis rather than in DNA repair. The gene discussed is TP53; the disease is lung carcinoma.